Perceptive Advisors - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 143 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$72,500
-99.9%
100,000
-87.7%
0.00%
-99.9%
Q2 2023$73,976,570
+102.0%
812,037
+46.2%
2.14%
+97.9%
Q1 2023$36,630,490
+46.4%
555,344
+51.6%
1.08%
+49.0%
Q3 2022$25,025,000
+72.2%
366,400
+14.0%
0.73%
+59.6%
Q2 2022$14,529,000
-80.7%
321,300
-78.3%
0.46%
-69.8%
Q1 2022$75,285,000
-45.2%
1,481,700
-49.0%
1.51%
+42.4%
Q4 2021$137,272,000
+577.2%
2,903,400
+372.1%
1.06%
+260.2%
Q3 2021$20,270,000
-75.7%
615,000
-53.5%
0.29%
-45.9%
Q2 2021$83,570,000
+22304.8%
1,322,324
+11481.0%
0.54%
+8950.0%
Q2 2020$373,000
+14.1%
11,4180.0%0.01%
-33.3%
Q1 2020$327,00011,4180.01%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders